Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) …

JR Nebeker, R Virmani, CL Bennett, JM Hoffman… - Journal of the American …, 2006 - jacc.org
Objectives: We undertook the review of all available cases of hypersensitivity reactions after
placement of a drug-eluting stent (DES) and classified potential causes. Background: Six …

Off‐label drug use in oncology: a systematic review of literature

MM Saiyed, PS Ong, L Chew - Journal of clinical pharmacy …, 2017 - Wiley Online Library
What is known and objective The off‐label use of medicines is widespread in several
diseases. This type of prescribing practice is particularly more acute in oncology. However …

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and …

KR Carson, AM Evens, EA Richey… - Blood, The Journal …, 2009 - ashpublications.org
Rituximab improves outcomes for persons with lymphoproliferative disorders and is
increasingly used to treat immune-mediated illnesses. Recent reports describe 2 patients …

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy

D Hershman, AI Neugut, JS Jacobson… - Journal of the …, 2007 - academic.oup.com
Background Recently, increasing numbers of women receiving adjuvant chemotherapy for
breast cancer have also received granulocyte colony-stimulating factors (G-CSFs) or …

Cyclooxygenase inhibition and cardiovascular risk

EM Antman, D DeMets, J Loscalzo - Circulation, 2005 - Am Heart Assoc
Over the past several months clinicians have been con-fronted at an escalating rate with
reports describing the risks of COX-2 inhibitors (coxibs). Information on this class of drugs …

Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or …

SM Trifilio, CL Bennett, PR Yarnold… - Bone marrow …, 2007 - nature.com
Zygomycosis is increasingly reported as a cause of life-threatening fungal infections. A
higher proportion of cases reported over the last decades have been in cancer patients, with …

AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program

R Chou, N Aronson, D Atkins, AS Ismaila… - Journal of clinical …, 2010 - Elsevier
Comparative effectiveness reviews (CERs) are systematic reviews that evaluate evidence
on alternative interventions to help clinicians, policy makers, and patients make informed …

User involvement in healthcare technology development and assessment: structured literature review

S Ghulam Sarwar Shah, I Robinson - International Journal of Health …, 2006 - emerald.com
Purpose–Medical device users are one of the principal medical device technology
stakeholders. The involvement of users in medical device technology development and …

Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review …

BJ Edwards, AD Bunta, J Lane, C Odvina, DS Rao… - JBJS, 2013 - journals.lww.com
Background: In the United States, hip fracture rates have declined by 30% coincident with
bisphosphonate use. However, bisphosphonates are associated with sporadic cases of …

Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study

KR Page, F Sifakis, RM De Oca… - Archives of Internal …, 2006 - jamanetwork.com
Background Treatment of latent tuberculosis infection (LTBI) is an important aspect of
tuberculosis control in the United States, but the effectiveness of this strategy is …